{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:41:54Z","timestamp":1782351714947,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Provincial Research Project of Public Welfare Technology","award":["LGF19H020003"],"award-info":[{"award-number":["LGF19H020003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Catheter ablation has been recommended for patients with symptomatic atrial fibrillation (AF), with pulmonary vein isolation being the cornerstone of the ablation procedure. Newly developed technologies, such as cryoballoon ablation with a second-generation cryoballoon (CB2) and the contact force radiofrequency (CF-RF) ablation, have been introduced in recent years to overcome the shortcomings of the widely used RF ablation approach. However, high-quality results comparing CB2 and CF-RF remain controversial. Thus, we conducted this meta-analysis to assess the efficacy and safety between CB2 and CF-RF using evidence from randomized controlled trials (RCTs). Databases including Embase, PubMed, the Cochrane Library, and ClinicalTrials.gov were systematically searched from their date of inception to January 2021. Only RCTs that met the inclusion criteria were included for analysis. The primary outcome of interest was freedom from atrial tachyarrhythmia (AT) during follow-up. Secondary outcomes included procedure-related complications, procedure time and fluoroscopy time. Six RCTs with a total of 987 patients were finally enrolled. No significant differences were found between CB2 and CF-RF in terms of freedom from AT (relative risk [RR]\u2009=\u20091.03, 95% confidence interval [CI] 0.92\u20131.14,<jats:italic>p<\/jats:italic>\u2009=\u20090.616) or total procedural-related complications (RR\u2009=\u20091.25, 95% CI 0.69\u20132.27,<jats:italic>p<\/jats:italic>\u2009=\u20090.457). CB2 treatment was associated with a significantly higher risk of phrenic nerve palsy (PNP) than CF-RF (RR\u2009=\u20094.93, 95% CI 1.12\u201321.73,<jats:italic>p<\/jats:italic>\u2009=\u20090.035). The occurrences of pericardial effusion\/tamponade and vascular complications were comparable between the CB2 and CF-RF treatments (RR\u2009=\u20090.41,<jats:italic>p<\/jats:italic>\u2009=\u20090.398; RR\u2009=\u20090.82,<jats:italic>p<\/jats:italic>\u2009=\u20090.632). In addition, CB2 treatment had a significantly shorter procedure time than CF-RF (weighted mean difference [WMD]\u2009=\u2009\u2212\u200920.75\u00a0min, 95% CI \u2212\u200925.44\u2009~\u2009\u2212\u200916.05\u00a0min,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), whereas no difference was found in terms of fluoroscopy time (WMD\u2009=\u20094.63\u00a0min,<jats:italic>p<\/jats:italic>\u2009=\u20090.179). CB2 and CF-RF treatment are comparable for AF patients regarding freedom from AT and procedure-related complications. Compared to CF-RF, CB2 treatment was associated with a shorter procedure time but a higher incidence of PNP. Further large-scale studies are warranted to compare these two techniques and provide an up-to-date recommendation.<\/jats:p>","DOI":"10.1038\/s41598-021-96820-8","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:06:24Z","timestamp":1631181984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Second-generation cryoballoon versus contact force radiofrequency ablation for atrial fibrillation: an updated meta-analysis of evidence from randomized controlled trials"],"prefix":"10.1038","volume":"11","author":[{"given":"Chenxia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"96820_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel, R. B. et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet 386, 154\u2013162 (2015).","journal-title":"Lancet"},{"key":"96820_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks, G. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373\u2013498 (2021).","journal-title":"Eur. Heart J."},{"key":"96820_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer, D. L. et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The cabana randomized clinical trial. JAMA 321, 1261\u20131274 (2019).","journal-title":"JAMA"},{"key":"96820_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2019.0335","volume":"321","author":"C Blomstr\u00f6m-Lundqvist","year":"2019","unstructured":"Blomstr\u00f6m-Lundqvist, C. et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: The CAPTAF randomized clinical trial. JAMA 321, 1059\u20131068 (2019).","journal-title":"JAMA"},{"key":"96820_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jama.2014.467","volume":"311","author":"CA Morillo","year":"2014","unstructured":"Morillo, C. A. et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): A randomized trial. JAMA 311, 692\u2013700 (2014).","journal-title":"JAMA"},{"key":"96820_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","volume":"133","author":"L Di Biase","year":"2016","unstructured":"Di Biase, L. et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC multicenter randomized trial. Circulation 133, 1637\u20131644 (2016).","journal-title":"Circulation"},{"key":"96820_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche, N. F. et al. Catheter ablation for atrial fibrillation with heart failure. N. Engl. J. Med. 378, 417\u2013427 (2018).","journal-title":"N. Engl. J. Med."},{"key":"96820_CR8","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","volume":"140","author":"JG Andrade","year":"2019","unstructured":"Andrade, J. G. et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: A randomized clinical trial. Circulation 140, 1779\u20131788 (2019).","journal-title":"Circulation"},{"key":"96820_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00392-018-1211-9","volume":"107","author":"TJ Buist","year":"2018","unstructured":"Buist, T. J., Adiyaman, A., Smit, J. J. J., Ramdat Misier, A. R. & Elvan, A. Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation. Clin Res Cardiol. 107, 498\u2013506 (2018).","journal-title":"Clin Res Cardiol."},{"key":"96820_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10840-016-0191-9","volume":"48","author":"J Jiang","year":"2017","unstructured":"Jiang, J., Li, J., Zhong, G. & Jiang, J. Efficacy and safety of the second-generation cryoballoons versus radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: A systematic review and meta-analysis. J. Interv. Card. Electrophysiol. 48, 69\u201379 (2017).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"96820_CR11","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1111\/jce.14676","volume":"31","author":"V Ravi","year":"2020","unstructured":"Ravi, V. et al. A systematic review and meta-analysis comparing second-generation cryoballoon and contact force radiofrequency ablation for initial ablation of paroxysmal and persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 31, 2559\u20132571 (2020).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"96820_CR12","doi-asserted-by":"crossref","unstructured":"Higgins JPT, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane. www.training.cochrane.org\/handbook (2019).","DOI":"10.1002\/9781119536604"},{"key":"96820_CR13","first-page":"43","volume":"20","author":"MA Gunawardene","year":"2018","unstructured":"Gunawardene, M. A. et al. Influence of energy source on early atrial fibrillation recurrences: A comparison of cryoballoon vs. radiofrequency current energy ablation with the endpoint of unexcitability in pulmonary vein isolation. Europace 20, 43\u201349 (2018).","journal-title":"Europace"},{"key":"96820_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/pace.13293","volume":"41","author":"R Watanabe","year":"2018","unstructured":"Watanabe, R. et al. Head-to-head comparison of acute and chronic pulmonary vein stenosis for cryoballoon versus radiofrequency ablation. Pacing Clin. Electrophysiol. 41, 376\u2013382 (2018).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"96820_CR15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jce.13933","volume":"30","author":"G Giannopoulos","year":"2019","unstructured":"Giannopoulos, G. et al. Effect of cryoballoon and radiofrequency ablation for pulmonary vein isolation on left atrial function in patients with nonvalvular paroxysmal atrial fibrillation: A prospective randomized study (Cryo-LAEF study). J. Cardiovasc. Electrophysiol. 30, 991\u2013998 (2019).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"96820_CR16","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1038\/s41598-019-44168-5","volume":"9","author":"L You","year":"2019","unstructured":"You, L. et al. Effects of different ablation strategies on long-term left atrial function in patients with paroxysmal atrial fibrillation: A single-blind randomized controlled trial. Sci. Rep. 9, 7695 (2019).","journal-title":"Sci. Rep."},{"key":"96820_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Ha\u00efssaguerre","year":"1998","unstructured":"Ha\u00efssaguerre, M. et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339, 659\u2013666 (1998).","journal-title":"N. Engl. J. Med."},{"key":"96820_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/europace\/eus304","volume":"15","author":"B Aldhoon","year":"2013","unstructured":"Aldhoon, B., Wichterle, D., Peichl, P., \u010cih\u00e1k, R. & Kautzner, J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 15, 24\u201332 (2013).","journal-title":"Europace"},{"key":"96820_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/europace\/euw027","volume":"19","author":"R Providencia","year":"2017","unstructured":"Providencia, R. et al. Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: Is cryoablation more reproducible?. Europace 19, 48\u201357 (2017).","journal-title":"Europace"},{"key":"96820_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-020-00878-9","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Comparative efficacy and safety of catheter ablation interventions for atrial fibrillation: Comprehensive network meta-analysis of randomized controlled trials. J. Interv. Card. Electrophysiol. https:\/\/doi.org\/10.1007\/s10840-020-00878-9 (2020).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"96820_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"KH Kuck","year":"2016","unstructured":"Kuck, K. H. et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 374, 2235\u20132245 (2016).","journal-title":"N. Engl. J. Med."},{"key":"96820_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.amjcard.2020.01.016","volume":"125","author":"F Fortuni","year":"2020","unstructured":"Fortuni, F. et al. Meta-analysis comparing cryoballoon versus radiofrequency as first ablation procedure for atrial fibrillation. Am. J. Cardiol. 125, 1170\u20131179 (2020).","journal-title":"Am. J. Cardiol."},{"key":"96820_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1253\/circj.CJ-15-1051","volume":"80","author":"S Miyazaki","year":"2016","unstructured":"Miyazaki, S. et al. Early recurrence after pulmonary vein isolation of paroxysmal atrial fibrillation with different ablation technologies\u2014Prospective comparison of radiofrequency vs. second-generation cryoballoon ablation. Circ. J. 80, 346\u2013353 (2016).","journal-title":"Circ. J."},{"key":"96820_CR24","doi-asserted-by":"publisher","first-page":"e0206362","DOI":"10.1371\/journal.pone.0206362","volume":"13","author":"M Shao","year":"2018","unstructured":"Shao, M. et al. The safety and efficacy of second-generation cryoballoon ablation plus catheter ablation for persistent atrial fibrillation: A systematic review and meta-analysis. PLoS One. 13, e0206362 (2018).","journal-title":"PLoS One."},{"key":"96820_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/europace\/euu350","volume":"17","author":"G Ciconte","year":"2015","unstructured":"Ciconte, G. et al. Circumferential pulmonary vein isolation as index procedure for persistent atrial fibrillation: A comparison between radiofrequency catheter ablation and second-generation cryoballoon ablation. Europace 17, 559\u2013565 (2015).","journal-title":"Europace"},{"key":"96820_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10840-014-9883-1","volume":"40","author":"S Knecht","year":"2014","unstructured":"Knecht, S., Kuhne, M., Osswald, S. & Sticherling, C. Quantitative assessment of a second-generation cryoballoon ablation catheter with new cooling technology\u2014a perspective on potential implications on outcome. J. Interv. Card. Electrophysiol. 40, 17\u201321 (2014).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"96820_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.hrthm.2017.01.003","volume":"14","author":"A Voskoboinik","year":"2017","unstructured":"Voskoboinik, A. et al. Revisiting pulmonary vein isolation alone for persistent atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm 14, 661\u2013667 (2017).","journal-title":"Heart Rhythm"},{"key":"96820_CR28","doi-asserted-by":"publisher","first-page":"e002476","DOI":"10.1161\/JAHA.115.002476","volume":"4","author":"M Shurrab","year":"2015","unstructured":"Shurrab, M. et al. Impact of Contact Force Technology on Atrial Fibrillation Ablation: A Meta-Analysis. J Am Heart Assoc. 4, e002476 (2015).","journal-title":"J Am Heart Assoc."},{"key":"96820_CR29","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.jacc.2015.09.088","volume":"66","author":"J Vogler","year":"2015","unstructured":"Vogler, J. et al. Pulmonary vein isolation versus defragmentation: The CHASE-AF clinical trial. J Am Coll Cardiol. 66, 2743\u20132752 (2015).","journal-title":"J Am Coll Cardiol."},{"key":"96820_CR30","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18, 1609\u20131678 (2016).","journal-title":"Europace"},{"key":"96820_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/europace\/eux233","volume":"20","author":"Y De Greef","year":"2018","unstructured":"De Greef, Y. et al. Complications of pulmonary vein isolation in atrial fibrillation: Predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry. Europace 20, 1279\u20131286 (2018).","journal-title":"Europace"},{"key":"96820_CR32","first-page":"1303","volume":"38","author":"E Arbelo","year":"2017","unstructured":"Arbelo, E. et al. Contemporary management of patients undergoing atrial fibrillation ablation: In-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 38, 1303\u20131316 (2017).","journal-title":"Eur Heart J."},{"key":"96820_CR33","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.hrthm.2011.07.025","volume":"8","author":"H Hoyt","year":"2011","unstructured":"Hoyt, H. et al. Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors. Heart Rhythm 8, 1869\u20131874 (2011).","journal-title":"Heart Rhythm"},{"key":"96820_CR34","first-page":"240","volume":"13","author":"H Ma","year":"2017","unstructured":"Ma, H. et al. Efficacy and safety of cryoballoon ablation versus radiofrequency catheter ablation in atrial fibrillation: An updated meta-analysis. Postepy. Kardiol. Interwencyjnej. 13, 240\u2013249 (2017).","journal-title":"Postepy. Kardiol. Interwencyjnej."},{"key":"96820_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jacep.2016.07.002","volume":"3","author":"KRJ Chun","year":"2017","unstructured":"Chun, K. R. J. et al. Complications in catheter ablation of atrial fibrillation in 3,000 consecutive procedures: Balloon versus radiofrequency current ablation. JACC Clin. Electrophysiol. 3, 154\u2013161 (2017).","journal-title":"JACC Clin. Electrophysiol."},{"key":"96820_CR36","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/eurheartj\/ehw285","volume":"37","author":"KH Kuck","year":"2016","unstructured":"Kuck, K. H. et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: Reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 37, 2858\u20132865 (2016).","journal-title":"Eur Heart J."},{"key":"96820_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ijcard.2014.11.105","volume":"179","author":"F Akca","year":"2015","unstructured":"Akca, F., Janse, P., Theuns, D. A. & Szili-Torok, T. A prospective study on safety of catheter ablation procedures: Contact force guided ablation could reduce the risk of cardiac perforation. Int J Cardiol. 179, 441\u2013448 (2015).","journal-title":"Int J Cardiol."},{"key":"96820_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0972-6292(16)30479-X","volume":"12","author":"JG Andrade","year":"2012","unstructured":"Andrade, J. G. et al. Cryoballoon ablation for atrial fibrillation. Indian Pacing Electrophysiol J. 12, 39\u201353 (2012).","journal-title":"Indian Pacing Electrophysiol J."},{"key":"96820_CR39","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.hrthm.2013.07.005","volume":"10","author":"R Casado-Arroyo","year":"2013","unstructured":"Casado-Arroyo, R. et al. Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: A comparison between the first- and second-generation balloon. Heart Rhythm 10, 1318\u20131324 (2013).","journal-title":"Heart Rhythm"},{"key":"96820_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/CIRCEP.113.001238","volume":"7","author":"B Mond\u00e9sert","year":"2014","unstructured":"Mond\u00e9sert, B. et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ. Arrhythm. Electrophysiol. 7, 605\u2013611 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"96820_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/1573403X15666181212102419","volume":"15","author":"N Patel","year":"2019","unstructured":"Patel, N. et al. Cryoballoon ablation for the treatment of atrial fibrillation: A meta-analysis. Curr. Cardiol. Rev. 15, 230\u2013238 (2019).","journal-title":"Curr. Cardiol. Rev."},{"key":"96820_CR42","doi-asserted-by":"publisher","first-page":"e006043","DOI":"10.1161\/JAHA.117.006043","volume":"6","author":"KRJ Chun","year":"2017","unstructured":"Chun, K. R. J. et al. The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: An economic analysis from the FIRE AND ICE Trial. J. Am. Heart Assoc. 6, e006043 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"96820_CR43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jval.2019.02.001","volume":"22","author":"J Ming","year":"2019","unstructured":"Ming, J. et al. Cost-effectiveness of cryoballoon ablation versus radiofrequency ablation for paroxysmal atrial fibrillation in China: Results based on real-world data. Value Health. 22, 863\u2013870 (2019).","journal-title":"Value Health."},{"key":"96820_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/europace\/euw262","volume":"19","author":"A Buiatti","year":"2017","unstructured":"Buiatti, A. et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: An updated meta-analysis of randomized and observational studies. Europace 19, 378\u2013384 (2017).","journal-title":"Europace"},{"key":"96820_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/europace\/euu215","volume":"17","author":"F Jourda","year":"2015","unstructured":"Jourda, F. et al. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace 17, 225\u2013231 (2015).","journal-title":"Europace"},{"key":"96820_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/CIRCEP.109.872093","volume":"2","author":"JD Ferguson","year":"2009","unstructured":"Ferguson, J. D. et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ. Arrhythm. Electrophysiol. 2, 611\u2013619 (2009).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"96820_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2217\/cer-2019-0165","volume":"9","author":"D Gupta","year":"2020","unstructured":"Gupta, D. et al. Comparative effectiveness of catheter ablation devices in the treatment of atrial fibrillation: A network meta-analysis. J. Comp. Eff. Res. 9, 115\u2013126 (2020).","journal-title":"J. Comp. Eff. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96820-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T15:31:20Z","timestamp":1699457480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96820-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96820-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17907"}}